Health Care & Life Sciences » Pharmaceuticals | Kyongbo Pharmaceutical Co. Ltd.

Kyongbo Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,445
6,953
4,404
4,580
6,404
4,986
Total Accounts Receivable
45,625
47,151
50,791
49,255
54,649
67,287
Inventories
32,202
43,107
49,522
47,569
47,964
53,494
Other Current Assets
350
265
391
822
1,621
3,169
Total Current Assets
84,622
97,477
105,108
102,227
110,638
128,936
Net Property, Plant & Equipment
43,797
55,285
74,892
83,949
78,497
76,497
Total Investments and Advances
1,522
2,854
4,055
2,950
1,222
1,410
Intangible Assets
1,655
2,069
1,644
3,351
2,584
2,499
Other Assets
-
-
-
1,675
1,321
-
Total Assets
143,383
168,035
197,937
206,733
206,133
221,623
ST Debt & Current Portion LT Debt
29,511
37,278
34,090
41,083
28,376
Accounts Payable
26,960
29,088
16,602
15,717
15,451
Income Tax Payable
3,477
17,555
2,631
1,441
5,788
Other Current Liabilities
536
1,695
11,219
14,476
10,765
Total Current Liabilities
60,484
85,616
64,542
72,717
60,379
Long-Term Debt
6,750
10,000
5,000
-
451
Provision for Risks & Charges
9,784
3,887
2,936
1,335
2,230
Deferred Taxes
11,787
10,350
9,789
9,584
10,607
Other Liabilities
146
202
194
282
300
Total Liabilities
77,164
99,705
75,120
77,331
64,623
Common Equity (Total)
66,219
68,330
122,817
129,402
141,510
Total Shareholders' Equity
66,219
68,330
122,817
129,402
141,510
Total Equity
66,219
68,330
122,817
129,402
141,510
Liabilities & Shareholders' Equity
143,383
168,035
197,937
206,733
206,133

About Kyongbo Pharmaceutical Co.

View Profile
Address
174 Sirok-ro
Asan SC 31501
Korea, Republic Of
Employees -
Website http://www.kbpharma.co.kr
Updated 07/08/2019
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include general, antibiotic, anticancer active pharmaceutical ingredients, inhalation anesthetic, cefaclor capsule and cefaclor dried syrup. The company was founded on March 31, 1987 and is headquartered in Asan, South Korea.